Vaccine News and Research

Latest Vaccine News and Research

BioCote Silver Ion Antimicrobial Technology makes surfaces inhospitable to influenza viruses

Strike a chord please, especially in light of the BMJ's article on Tuesday about the ineffectiveness of the flu vaccine for elderly last year - just wanted to make you also aware of the ultimate surface protection against viruses like H1N1, plus all the proliferating superbugs.

11 Sep 2017

Meningitis B vaccine’s high price tag poses a health care conundrum

Four years ago, when meningitis B, an extremely rare but potentially lethal form of the infection, sickened a small number of college students at Princeton and the University of California-Santa Barbara, there was no vaccine against the disease sold in the U.S. Despite its availability abroad, it had never been licensed in the country due to its limited marketability.

8 Sep 2017

Newest vaccine highly effective at preventing nine types of HPV infection, study shows

Cervical cancer is the second most common cause of cancer-related death worldwide, with almost 300,000 deaths occurring each year. More than 80 percent of these deaths occur in developing nations.

7 Sep 2017

Study describes link between key melanoma signaling pathway and novel class of drugs

Results of a study by The Wistar Institute have described a correlation between a key melanoma signaling pathway and a novel class of drugs being tested in the clinic as adjuvant therapy for advanced melanoma, providing useful information for a more effective use of this type of treatment.

7 Sep 2017

Novel compounds found to be highly effective in preventing transmission of malaria parasites

Significant headway has been made in controlling malaria. However, two vexing problems remain: currently available treatments are unable to block transmission of the parasite that causes the disease, and the parasite often becomes resistant to drugs.

7 Sep 2017

Study finds long-term effectiveness of HPV vaccine in preventing cervical cancer

A vaccine that can literally eradicate the majority of cervical cancer cases shows long-term effectiveness in a study published today in The Lancet.

6 Sep 2017

Another way for anti-vaxxers to skip shots for schoolkids: A doctor’s note

Dr. Tara Zandvliet was inundated with calls and emails from parents last year, after California passed a law nixing personal beliefs as an exemption from school vaccinations. Suddenly, many parents sought exemptions for medical reasons.

5 Sep 2017

Research provides novel insights into bacterial toxins

A toxin produced by a bacterium that causes urinary tract infections is related to, yet different in key ways from, the toxin that causes whooping cough, according to new research.

5 Sep 2017

Hepatitis A outbreak among population of San Diego

The San Diego population is facing one of the worst outbreaks of infective viral disease Hepatitis A. the outbreak began last November and is still going strong with no signs of reduction in the infection rates. The homeless are one of the worst hit.

3 Sep 2017

Vaccination efforts in poor countries prevent 20 million deaths, provide economic benefits

Vaccination efforts made in the world's poorest countries since 2001 will have prevented 20 million deaths and saved $350 billion in health-care costs by 2020, according to a new study from the University of North Carolina at Chapel Hill.

1 Sep 2017

BCG vaccine protects against infection in adulthood when most transmission occurs, study shows

Previously thought to be effective for 10-15 years, a new case-control study found that if given in early teenage years (12-13), the Bacillus Calmette-Guérin (BCG) vaccine protected over 50% of UK children against TB for at least 20 years, then waned.

1 Sep 2017

St. Kitts launches probe of herpes vaccine tests on U.S. patients

The government of St. Kitts and Nevis has launched an investigation into the clinical trial for a herpes vaccine by an American company because it said its officials were not notified about the experiments.

31 Aug 2017

Experimental drug isolated from tick saliva may hold promise for reducing HIV-linked heart disease risk

Scientists may have found a clue to why people living with HIV have double the likelihood of developing heart disease.

30 Aug 2017

$Novartis gets FDA approval for novel immunocellular therapy to treat relapsed or refractory B-cell ALL$

Novartis gets FDA approval for novel immunocellular therapy to treat relapsed or refractory B-cell ALL

Novartis announced today that the US Food and Drug Administration has approved Kymriah (tisagenlecleucel) suspension for intravenous infusion, formerly CTL019, the first chimeric antigen receptor T cell (CAR-T) therapy, for the treatment of patients up to 25 years of age with B-cell precursor acute lymphoblastic leukemia (ALL) that is refractory or in second or later relapse.

30 Aug 2017

Study finds low HPV vaccination rates among childhood cancer survivors

The rate of human papilloma virus (HPV) vaccination in the United States is increasing, but remains lower than ideal. A new study suggests that survivors of childhood cancer receive the HPV vaccine at an even lower rate than their peers without cancer ̶ 24% versus 40%. Nearly three quarters of study participants reported that their healthcare provider did not proactively recommend vaccination.

29 Aug 2017

Immune booster could improve effectiveness of vaccines and cancer immunotherapy

Vaccines and cancer immunotherapies do essentially the same thing: They boost a person's immune system, better enabling it to fight an offender, be it microbe or malignancy.

29 Aug 2017

Offshore rush for herpes vaccine roils debate over U.S. safety rules

Defying U.S. safety protections for human trials, an American university and a group of wealthy libertarians, including a prominent Donald Trump supporter, are backing the offshore testing of an experimental herpes vaccine.

28 Aug 2017

Simultaneous treatment with anti-PD1 and anti-OX40 cancer therapies may have detrimental effect

Concurrent administration of the T-cell stimulating anti-OX40 antibody and the immune checkpoint inhibitor anti-PD1 antibody attenuated the effect of anti-OX40 and resulted in poor treatment outcomes in mice.

28 Aug 2017

Studies reveal strategies for using shingles vaccine in arthritis patients

New research indicates that the live varicella-zoster vaccine--which is given to protect against shingles--elicits robust immune responses in patients when administered several weeks prior to the start of treatment with the arthritis drug tofacitinib.

28 Aug 2017

SLU-led project receives NIH funding for clinical trial on potential treatment for MDR-TB

Saint Louis University is leading a multi-national clinical trial of what could become a regimen for drug resistant tuberculosis (TB) that does not require injectable medications. The project is funded by a $6.4 million task order from the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health.

26 Aug 2017

Vaccine News and Research

Latest Vaccine News and Research

BioCote Silver Ion Antimicrobial Technology makes surfaces inhospitable to influenza viruses

Meningitis B vaccine’s high price tag poses a health care conundrum

Newest vaccine highly effective at preventing nine types of HPV infection, study shows

Study describes link between key melanoma signaling pathway and novel class of drugs

Novel compounds found to be highly effective in preventing transmission of malaria parasites

Study finds long-term effectiveness of HPV vaccine in preventing cervical cancer

Another way for anti-vaxxers to skip shots for schoolkids: A doctor’s note

Research provides novel insights into bacterial toxins

Hepatitis A outbreak among population of San Diego

Vaccination efforts in poor countries prevent 20 million deaths, provide economic benefits

BCG vaccine protects against infection in adulthood when most transmission occurs, study shows

St. Kitts launches probe of herpes vaccine tests on U.S. patients

Experimental drug isolated from tick saliva may hold promise for reducing HIV-linked heart disease risk

Novartis gets FDA approval for novel immunocellular therapy to treat relapsed or refractory B-cell ALL

Study finds low HPV vaccination rates among childhood cancer survivors

Immune booster could improve effectiveness of vaccines and cancer immunotherapy

Offshore rush for herpes vaccine roils debate over U.S. safety rules

Simultaneous treatment with anti-PD1 and anti-OX40 cancer therapies may have detrimental effect

Studies reveal strategies for using shingles vaccine in arthritis patients

SLU-led project receives NIH funding for clinical trial on potential treatment for MDR-TB

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Scaling organ‑chip technology for human‑relevant drug discovery

Unlocking drug amorphization: Continuous, solvent-free twin screw granulation

How can super-resolution technology help study neurotransmission?

Vaccine News and Research

Latest Vaccine News and Research

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Scaling organ‑chip technology for human‑relevant drug discovery

Unlocking drug amorphization: Continuous, solvent-free twin screw granulation

How can super-resolution technology help study neurotransmission?

Newsletters you may be interested in